By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Company Seeking Type 1 Diabetes Early Detection Tool
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Company Seeking Type 1 Diabetes Early Detection Tool
FinanceMedical DevicesMedical InnovationsTechnology

Company Seeking Type 1 Diabetes Early Detection Tool

Deanna Pogorelc
Deanna Pogorelc
Share
3 Min Read
SHARE

Originally published on MedCityNews.com.

biomarker panelA young diagnostics company has turned a $500,000 SBIR grant it won last year into an assay that it hopes will eventually help researchers and clinicians detect and diagnose type 1 diabetes earlier.

Originally published on MedCityNews.com.

biomarker panelA young diagnostics company has turned a $500,000 SBIR grant it won last year into an assay that it hopes will eventually help researchers and clinicians detect and diagnose type 1 diabetes earlier.

More Read

Image
Sinai Surgeon Dr. Yassar Youssef Performs Scarless Gallbladder Surgery
Key Recent Developments in Diabetes Research
4 Tips for Getting Medical Staff Buy-In on New Office Technology
Four Health Innovation Drivers
3 Major Technologies Providers Need for Population Health Management

Genalyte Inc. recently launched its first multiplexed antigen panel for type 1 diabetes. The biomarker panel measures seven autoantibodies associated with the destruction of pancreatic islet cells that’s characteristic of the disease.

The product itself is a disposable silicon chip that goes into the company’s Maverick Detection System. Using a technology called silicon photonics, the device measures protein binding between antibodies and antigens in a single small sample. It eliminates the need for complex sample processing steps associated with current multiplexed testing, like washing, incubation and use of reagents, and delivers results within 15 minutes, the company says.

JDRF estimates that as many as 3 million Americans live with T1D, which is managed with careful attention to eating and activity, and administration of insulin injections. Symptoms often come on quickly, so diagnosis is often made in a hospital or emergency room. A biomarker test could be a helpful tool for clinicians, given that a strong pipeline of new devices and therapies for treatment of diabetes continues to advance.

“The unique capabilities of our Maverick detection platform have the potential to provide researchers and clinicians with tools to detect and track this process from an early stage, when interventions to interrupt the disease process may be feasible,” said Genalyte’s chief scientific officer, Martin Gleeson, in a statement.

For now, though, the panel is only available for research use. “It is our intention to continue to develop the T1D panel with the ultimate goal of providing a lab test and/or point of care test,” Gleeson said in an email. “We cannot disclose timelines at this point in the development cycle.”

Meanwhile, the company is also developing a series of other panels for immune-related disorders and collaborating with the Barbara Davis Diabetes Center at the University of Colorado on more advanced tools for identifying T1D.

The 6-year-old San Diego company is backed by Redmile Group, Claremont Creek Ventures and other private investors.

TAGGED:diabetesGenalyte Inc.
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Image
BusinesseHealthHealth ReformHospital AdministrationMedical InnovationsMobile HealthPublic HealthTechnologyWellness

Designing Healthcare Innovation

March 31, 2013
medical scribe secrets
BusinessFinanceHospital AdministrationPolicy & LawPublic Health

The Disturbing Confessions of a Medical Scribe: Adding to the Bill

August 13, 2014

Yale Spinoff Licenses HER3 Cancer Drug from MedImmune

August 1, 2013

Could Drones Deliver Life-Saving Defibrillators for Heart Attack Victims?

September 10, 2013
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?